Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?

The recent development of once-daily antiretroviral agents and fixed-dose combination formulations has been an important development in antiretroviral regimen simplification. Recent studies indicate that once-daily antiretroviral regimens improve adherence, especially in antiretroviral-naïve patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachega, Jean B, Rosenkranz, Bernd, Pham, Paul A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259079/
https://www.ncbi.nlm.nih.gov/pubmed/22259241
http://dx.doi.org/10.2147/PPA.S27558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259079/
https://www.ncbi.nlm.nih.gov/pubmed/22259241
http://dx.doi.org/10.2147/PPA.S27558

Ejemplares similares